Promethazine Hydrochloride Injection — FDA Drug Shortage

Current — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on Nov 21, 2023. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-5550-6
Dosage Form
Injection
Presentation
Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)
Initial Posting
Nov 21, 2023

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.